This breakthrough could revolutionize antibiotic development strategies and provide hope for more effective treatments against Lyme disease and other bacterial infections.
Researchers at Duke Health have successfully tested a technique that utilizes a molecular facilitator called high-temperature protein G (HtpG) to target the Borrelia burgdoferi bacterium responsible for Lyme disease.
The HtpG inhibitor, combined with a photosensitive drug, was absorbed into the bacteria's cells and caused programmed cell death when exposed to light, effectively eradicating the bacteria.
The findings open up new possibilities for antibiotic development by exploring unexplored druggable areas within bacteria to deliver cellular toxins.
This method also shows potential for targeting other bacteria, fungi, and viruses.
The study was funded by the Steven and Alexander Cohen Foundation and the Bay Area Lyme Foundation.
Duke researchers have developed a groundbreaking method to effectively eliminate the bacterium responsible for Lyme disease. This discovery could lead to the development of more targeted and efficient treatments for Lyme disease and other bacterial infections, offering hope for improved patient outcomes.